Genting Berhad:戦略・SWOT・企業財務分析

◆英語タイトル:Genting Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015758
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Genting Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Genting Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genting Berhad (Genting or “the company”) is an investment holding and management company of Genting Group, which is engaged in power generation, oil palm plantations, property development, cruise, biotechnology, and oil and gas. The company primarily operates in the US, Asia, and the UK. It is headquartered in Kuala Lumpur, Malaysia and employed more than 60,000 people as on December 31, 2014.

Scope

- Detailed information on Genting Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genting Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Genting Berhad including a breakdown and examination of key business segments
- Intelligence on Genting Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genting Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genting Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genting Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genting Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Genting Berhad: Company Overview
Genting Berhad: Overview and Key Facts
Genting Berhad: Overview
Genting Berhad: Key Facts
Genting Berhad: Key Employees
Genting Berhad: Key Employee Biographies
Genting Berhad: Major Products and Services
Genting Berhad: Company History
Genting Berhad: Management Statement
Genting Berhad: Locations and Subsidiaries
Genting Berhad: Key Competitors
Genting Berhad: Company Analysis
Genting Berhad: Business Description
Genting Berhad: SWOT Analysis
Genting Berhad: SWOT Overview
Genting Berhad: Strengths
Genting Berhad: Weaknesses
Genting Berhad: Opportunities
Genting Berhad: Threats
Genting Berhad: Corporate Financial Deals Activity
Genting Berhad: Financial Deals Overview
Genting Berhad: Targets and Partners
Genting Berhad: Top Deals 2013 – 2017YTD*
Genting Berhad: Mergers and Acquisitions
Genting Berhad: Corporate Venturing
Genting Berhad: Divestments
Genting Berhad: Recent Developments
Genting Berhad: News and Events Summary
Genting Berhad: Corporate Governance
Genting Berhad: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Genting Berhad: Key Facts
Table 2: Genting Berhad: Key Employees
Table 3: Genting Berhad: Locations and Subsidiaries
Table 4: Genting Berhad: Key Competitors
Table 5: Genting Berhad: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Genting Berhad: M&A Average Deal Size - Value (US$m)
Table 7: Genting Berhad: Targets and Partners
Table 8: Genting Berhad: Top Deals 2013 - 2017YTD*
Table 9: Genting Berhad: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Genting Berhad: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 11: Genting Berhad: Corporate Venturing by Geography (2013 - YTD*2017)
Table 12: Genting Berhad: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 13: Genting Berhad: News and Events Summary
Table 14: Genting Berhad: Corporate Governance
Table 15: Genting Berhad: Financial Performance

★海外企業調査レポート[Genting Berhad:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProSciento Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that develops drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development and regulatory servi …
  • Sinochem International Corp (600500):企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ottogi Corporation:企業の戦略・SWOT・財務情報
    Ottogi Corporation - Strategy, SWOT and Corporate Finance Report Summary Ottogi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Paddy Power Betfair Plc
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Groupe Bruxelles Lambert SA:企業の戦略・SWOT・財務分析
    Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • Boehringer Ingelheim GmbH:企業の戦略的SWOT分析
    Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Pulmagen Therapeutics LLP:製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmagen Therapeutics LLP (Pulmagen) formerly Argenta Discovery Ltd, is a development stage pharmaceutical company, which develops oral and inhaled medicines for chronic respiratory diseases. The company’s product pipeline includes oral CRTh2 antagonists, inhaled bronchodilators, inhaled per …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • UNITIKA LTD.:企業の戦略・SWOT・財務分析
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Avacta Group Plc (AVCT):企業の製品パイプライン分析2018
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • LG Chem Ltd (051910):企業の財務・戦略的SWOT分析
    LG Chem Ltd (051910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aavin Equity Advisors, LLC:企業の戦略・SWOT・財務分析
    Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report Summary Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Occidental Petroleum Corporation:企業の戦略・SWOT・財務分析
    Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Aoyama Trading Co., Ltd.
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Worthington Industries Inc:企業の戦略・SWOT・財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Henry Schein Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Henry Schein Medical Systems Inc (HSMS), formerly MicroMD is a healthcare technology company that develops medical practice software solutions. The company provides practice management, EMR and document management software solutions for small practices, medical groups, community health cente …
  • Transplant Genomics Inc:企業の製品パイプライン分析2018
    Summary Transplant Genomics Inc (TGI) is a biotech company. The company carries out performing organ transplantation using non-invasive serial monitoring under the guidance of genomics. It aims in detecting early signs of graft injury by conducting molecular diagnostic tests, enabling in differentia …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆